CARsgen：satri-cel approved for marketing in China.
Genrix：GR1801 was approved
Lilly：Inluriyo ™ (imlunestrant)received marketing approval
ProteLight：Peceleganan was approved
Johnson & Johnson：Akeega®Niraparib and Abiraterone Acetate Tabletsapproved for marketing in China.
Antengene：Announces Exclusive License Agreement with K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE
BioMap and Harbour BioMed：Announce Landmark Strategic Partnership
Everest：Announces Exclusive Commercialization Licensing Agreement with Dimerix Limited
Lilly：4E Therapeutics, Inc. Announces Acquisition by Eli Lilly and Company
AstraZeneca：ULTOMIRIS®Ravulizumab marketing application submitted in the United States.
